← Back to Search

Spasticity Take Control for Multiple Sclerosis (STC Trial)

N/A
Waitlist Available
Led By Lucinda L. Hugos, PT MS
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up one month post-intervention
Awards & highlights

STC Trial Summary

This trial will compare the effects of two different ways to manage spasticity caused by MS in the legs. Both methods will be taught in group classes using video teleconferencing, and will involve exercises to lessen spasticity.

Eligible Conditions
  • Multiple Sclerosis

STC Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~one month post-intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and one month post-intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Impact of spasticity, measured by the Multiple Sclerosis Spasticity Scale-88
Secondary outcome measures
Fatigue, measured by the Modified Fatigue Impact Scale
Impact on day-to-day life, measured by the Multiple Sclerosis Impact Scale-29
Impact on multiple sclerosis on walking, measured by the Multiple Sclerosis Walking Scale-12
+5 more

STC Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Spasticity Take ControlExperimental Treatment1 Intervention
Participants will attend two 2-hour classes via video teleconference (online), one week apart, consisting of education and a stretching program for spasticity management.
Group II: Stretching for People with MS: An Illustrated ManualActive Control1 Intervention
Participants will attend two 2-hour classes via video teleconference (online), one week apart, consisting of education and exercises for spasticity management.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Spasticity Take Control
2018
N/A
~240

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,609 Previous Clinical Trials
3,306,202 Total Patients Enrolled
15 Trials studying Multiple Sclerosis
967 Patients Enrolled for Multiple Sclerosis
Oregon Health and Science UniversityOTHER
973 Previous Clinical Trials
7,385,581 Total Patients Enrolled
29 Trials studying Multiple Sclerosis
1,985 Patients Enrolled for Multiple Sclerosis
Lucinda L. Hugos, PT MSPrincipal InvestigatorVA Portland Health Care System, Portland, OR

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Evaluation of a Spasticity Management Program for People With Multiple Sclerosis
2018. "Evaluation of a Spasticity Management Program for People With Multiple Sclerosis". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03166930.
~32 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top